Hematology Practice Questions

Q: Which of the following is a significant risk factor for developing deep vein thrombosis (DVT)?

Recent surgery. **Recent surgery** - **Surgical procedures**, especially orthopedic surgeries (e.g., hip or knee replacement), cause **endothelial injury** and activate the coagulation cascade [3]. - The **postoperative period** is associated with reduced mobility and systemic inflammatory responses, significantly increasing the risk of **venous stasis** and **hypercoagulability** [2]. *Long periods of immobility* - While immobility is a significant contributor to DVT, it is a broader category of risk. **Recent surgery** often combines immobility with additional risk factors like tissue trauma and inflammation, making it a more specific and acute risk factor [2]. - **Venous stasis** due to immobility allows clotting factors to accumulate, promoting clot formation. *Use of oral contraceptives* - **Estrogen-containing oral contraceptives** increase the synthesis of clotting factors and decrease natural anticoagulants, leading to a **hypercoagulable state**. - While a risk factor, it is often a chronic predisposition rather than an acute precipitating factor like recent surgery. *Advanced age* - **Advanced age** is associated with an increased risk of DVT due to age-related changes in the coagulation system, endothelial function, and higher prevalence of comorbidities [1], [4]. - However, it is a general predisposing factor, whereas **recent surgery** represents a more immediate and potent trigger.

Q: A 50-year-old man presents with fatigue and dizziness. Blood work shows normocytic anemia with elevated ferritin levels. Genetic testing reveals a homozygous HFE mutation. What is the best treatment option for this condition?

Phlebotomy is the best treatment option.. PHLEBOTOMY IS THE BEST TREATMENT OPTION. - The patient's presentation with **fatigue, dizziness, normocytic anemia, elevated ferritin**, and a **homozygous HFE mutation** strongly suggests **hereditary hemochromatosis**. [1], [2] - **Phlebotomy** is the first-line treatment as it directly removes excess iron from the body by drawing blood, preventing organ damage. [1] *Transfusion with packed RBCs is recommended.* - **Transfusions** would further increase iron levels in a patient with **iron overload**, exacerbating the condition and potentially causing more harm. - This treatment is appropriate for severe symptomatic anemia due to **iron deficiency** or other causes, not iron overload. *Chelation therapy with deferoxamine is indicated.* - **Chelation therapy** is used for iron overload when phlebotomy is contraindicated (e.g., severe anemia, poor venous access) or ineffective. - While effective, **deferoxamine** is typically a second-line therapy for hereditary hemochromatosis, as phlebotomy is generally safer and more efficient. *High-dose corticosteroids should be used.* - **Corticosteroids** are anti-inflammatory and immunosuppressive agents, primarily used for autoimmune conditions or certain types of anemia (e.g., autoimmune hemolytic anemia). - They have **no role** in the treatment of **hereditary hemochromatosis** or iron overload.

Q: A 35-year-old woman presents with fatigue and pallor. A peripheral blood smear shows hypochromic, microcytic red blood cells with anisopoikilocytosis and a low reticulocyte count. What is the next best step in management?

Perform diagnostic tests to confirm iron deficiency.. ***Order serum ferritin and total iron-binding capacity (TIBC)*** - This test is essential to confirm **iron deficiency anemia**, indicated by hypochromic, microcytic red blood cells [1]. [1]. - Measurement of **serum ferritin** helps assess iron stores and **TIBC** can indicate the body's iron-binding capacity, guiding proper treatment. *Administer iron supplements and re-evaluate in 3 months* - While this may seem appropriate for **iron deficiency anemia**, it is premature without confirming the diagnosis through testing. - Immediate iron supplementation without evaluating iron status can lead to **excessive iron intake** if not needed [2]. *Transfuse packed red blood cells* - This option is used for **acute severe anemia** or significant symptoms, but not unless the diagnosis is clear [1]. - The current clinical presentation does not warrant immediate transfusion, as underlying causes need to be confirmed. *Perform bone marrow biopsy* - This is generally reserved for cases where there is suspicion of **bone marrow pathology** [3] or when other tests have not yielded results. - The presentation is more consistent with **iron deficiency**, making less invasive tests preferable initially.

Q: A 40-year-old woman presents with fatigue and pallor. A peripheral blood smear shows hypochromic microcytic anemia. She has a history of heavy menstrual bleeding. What is the most likely cause of her anemia?

Iron deficiency anemia. ***Iron deficiency anemia*** - The patient's **heavy menstrual bleeding** likely leads to **iron loss**, causing hypochromic microcytic anemia [1][2]. - The peripheral blood smear findings are characteristic of **iron deficiency**, which is the most common cause of anemia in women of reproductive age [1][2]. *Vitamin B12 deficiency* - Typically presents with **macrocytic anemia** and neurological symptoms, which are absent in this patient. - Blood smear would show **megaloblasts** rather than hypochromic microcytic cells. *Thalassemia minor* - Although it can cause **microcytic anemia**, it usually does not present with significant **fatigue** or **pallor** without a family history. - It is typically associated with an elevated **HbA2** level found in hemoglobin electrophoresis, which is not indicated here. *Sideroblastic anemia* - Characterized by the presence of **ringed sideroblasts** in the bone marrow, not typically seen in a peripheral smear. - It often presents with **microcytic anemia**, but causes are often related to **congenital disorders** or certain **toxins** rather than heavy menstrual bleeding.

Q: A patient with severe thrombocytopenia is given a platelet transfusion. What is the primary indication for this treatment?

To prevent bleeding. ***To prevent bleeding*** - The primary indication for platelet transfusion is to **prevent bleeding** in patients with severe thrombocytopenia [1]. - Low platelet counts significantly increase the risk of **spontaneous bleeding**, particularly in critical situations [1]. *To increase oxygen-carrying capacity* - This option is irrelevant as platelet transfusions do not influence **hemoglobin levels** or oxygen transport. - Oxygen-carrying capacity is primarily a function of **red blood cells**, not platelets. *To treat anemia* - Anemia is treated with **red blood cell transfusions**, not platelet transfusions. - Platelets are crucial for **clotting**, not for carrying oxygen to tissues. *To replace coagulation factors* - Coagulation factors are replaced with **fresh frozen plasma or factor concentrates**, not platelets. - Platelets play a role in **hemostasis**, but do not serve to replace factors that aid in blood clotting.

Q: A 35-year-old man presents with bone pain and high blood calcium levels. Imaging reveals lytic bone lesions, and a bone marrow biopsy shows plasma cell proliferation. Which serum protein is likely to be elevated?

IgG. Detailed explanation of the characteristic findings in multiple myeloma. ***IgG*** - Elevated **serum IgG** levels are characteristic of multiple myeloma, a condition marked by plasma cell proliferation and lytic bone lesions [1]. - High blood calcium levels, or **hypercalcemia**, are often associated with the release of osteoclastic factors by these expanded plasma cells. *IgE* - Primarily involved in **allergic reactions** and **parasitic infections**, not in multiple myeloma. - IgE levels do not correlate with **bone pain** or **lytic lesions**, making this option inappropriate. *Fibrinogen* - Not typically elevated in multiple myeloma; it is more associated with **inflammatory states** or **coagulation disorders**. - This protein does not indicate **plasma cell proliferation** or relate to the symptoms presented in bone pathology. *Albumin* - Generally a **negative acute phase reactant**; levels may actually decrease in systemic illness or malignancy. - Albumin does not contribute to the **diagnostic picture** of multiple myeloma or its typical serum protein elevation.

Q: A 35-year-old woman presents with fatigue, weakness, and pallor. Laboratory tests reveal microcytic hypochromic anemia, low serum ferritin, and increased total iron-binding capacity. What is the most likely cause of her condition?

Chronic blood loss. ***Chronic blood loss*** - Chronic blood loss is the most common cause of **iron deficiency anemia** in premenopausal women, leading to the **microcytic, hypochromic** red blood cells, low **ferritin**, and high **total iron-binding capacity (TIBC)** seen in this patient [1]. Menorrhagia is a particularly common cause in pre-menopausal females, necessitating a thorough history of menstrual cycles [2]. - The patient's fatigue, weakness, and pallor are classic symptoms of anemia, and the iron studies are highly indicative of iron depletion due to ongoing blood loss [1]. [2]. *Vitamin B12 deficiency* - Vitamin B12 deficiency typically causes **macrocytic (megaloblastic) anemia**, characterized by large red blood cells, which contradicts the **microcytic** finding in this case [2]. - It would not lead to low serum **ferritin** or increased **TIBC**; these are specific indicators of iron deficiency. *Hemolytic anemia* - Hemolytic anemia involves the premature destruction of red blood cells, often leading to **normocytic or macrocytic anemia**, elevated **reticulocyte count**, and signs like **jaundice** or **splenomegaly**, none of which are mentioned [2]. - It would not present with low **ferritin** and high **TIBC**, as these values point directly to iron deficiency. *Thalassemia* - Thalassemia is a genetic disorder causing **microcytic, hypochromic anemia**, but it is characterized by **normal or elevated iron stores** (including ferritin) and normal **TIBC**, as the problem is with globin chain synthesis, not iron availability. - The differential diagnosis often includes iron deficiency anemia, but the distinguishing iron studies (normal/high ferritin, normal TIBC) rule it out in this scenario.

Q: A patient with fatigue and pallor has a low hemoglobin level and a high total iron-binding capacity (TIBC). Which condition is most likely?

Iron Deficiency Anemia. ***Iron Deficiency Anemia*** - Characterized by **low hemoglobin** levels and **high total iron-binding capacity (TIBC)**, indicating low iron stores [1]. - Commonly presents with **fatigue** and **pallor**, consistent with this patient's symptoms [1]. *Sideroblastic Anemia* - Often presents with **normal or low TIBC**, as iron may be trapped in the mitochondria. - Symptoms may include **microcytic anemia**, but TIBC levels and presentation differ significantly from iron deficiency anemia. *Hemolytic Anemia* - Characterized by **increased reticulocyte count** and **normal to low TIBC**, as hemolysis leads to iron release [1]. - Symptoms typically include **jaundice** and **dark urine**, which are not mentioned here. *Anemia of Chronic Disease* - Typically presents with **low TIBC** and **normal or increased ferritin** due to sequestration of iron in chronic inflammation [1]. - Symptoms may overlap with other forms of anemia but would show different laboratory findings than in this case [1].

Q: Which of these is increased in iron deficiency anemia?

Total iron-binding capacity. ***Total iron-binding capacity*** - In **iron deficiency anemia**, the body tries to compensate by increasing the production of **transferrin**, the protein responsible for binding iron. [1] - This increase in unbound transferrin leads to a higher **total iron-binding capacity (TIBC)**, reflecting the increased potential for iron binding. [1] *Serum ferritin* - **Ferritin** is an iron storage protein, and its levels are typically **decreased** in iron deficiency anemia as the body mobilizes its iron reserves. [1] - Low serum ferritin is a highly sensitive and specific indicator of **iron depletion**. [1] *Serum transferrin saturation* - **Transferrin saturation** represents the percentage of transferrin binding sites occupied by iron. - In iron deficiency anemia, both **serum iron** and the iron bound to transferrin are low, leading to a **decreased** transferrin saturation. [1] *Serum iron* - **Serum iron** measures the amount of iron circulating in the blood, primarily bound to transferrin. - In iron deficiency anemia, the availability of iron is reduced, resulting in **decreased** serum iron levels. [1]

Q: Which of the following is the MOST COMMON condition that can lead to an abnormal Schilling test?

Intrinsic factor deficiency. Intrinsic factor deficiency - Pernicious anemia, caused by intrinsic factor deficiency, is the most common reason for an abnormal Schilling test due to impaired vitamin B12 absorption [1]. - In this condition, the stomach's parietal cells fail to produce intrinsic factor, which is essential for B12 absorption in the ileum [2]. Ileal disease - While ileal diseases (e.g., Crohn's disease, resection) can cause an abnormal Schilling test due to malabsorption of the B12-intrinsic factor complex, they are less common causes overall compared to pernicious anemia [2]. - The Schilling test would typically show low urinary excretion in both phases, but this is a secondary cause rather than the most frequent primary cause. Chronic pancreatitis - Chronic pancreatitis can lead to vitamin B12 malabsorption, but it's typically due to a failure to release B12 from its binding proteins in the stomach and duodenum, not a direct problem with intrinsic factor or ileal absorption. - This condition is a less common cause of an abnormal Schilling test, and the test's second phase (with intrinsic factor) usually corrects the malabsorption. None of the options - This option is incorrect because intrinsic factor deficiency is indeed a major and the most common cause of an abnormal Schilling test.

Question 1

Which of the following is a significant risk factor for developing deep vein thrombosis (DVT)?

Accepted Answer

Recent surgery

Answer

Advanced age

Answer

Use of oral contraceptives

Answer

Long periods of immobility

Question 2

A 50-year-old man presents with fatigue and dizziness. Blood work shows normocytic anemia with elevated ferritin levels. Genetic testing reveals a homozygous HFE mutation. What is the best treatment option for this condition?

Accepted Answer

Phlebotomy is the best treatment option.

Answer

Transfusion with packed RBCs is recommended.

Answer

Chelation therapy with deferoxamine is indicated.

Answer

High-dose corticosteroids should be used.

Question 3

A 35-year-old woman presents with fatigue and pallor. A peripheral blood smear shows hypochromic, microcytic red blood cells with anisopoikilocytosis and a low reticulocyte count. What is the next best step in management?

Accepted Answer

Perform diagnostic tests to confirm iron deficiency.

Answer

Start treatment with iron supplements and monitor response.

Answer

Conduct an invasive procedure to evaluate bone marrow.

Answer

Provide immediate blood transfusion for anemia.

Question 4

A 40-year-old woman presents with fatigue and pallor. A peripheral blood smear shows hypochromic microcytic anemia. She has a history of heavy menstrual bleeding. What is the most likely cause of her anemia?

Accepted Answer

Iron deficiency anemia

Answer

Thalassemia minor

Answer

Sideroblastic anemia

Answer

Vitamin B12 deficiency

Question 5

A patient with severe thrombocytopenia is given a platelet transfusion. What is the primary indication for this treatment?

Accepted Answer

To prevent bleeding

Answer

To increase oxygen-carrying capacity

Answer

To replace coagulation factors

Answer

To treat anemia

Question 6

A 35-year-old man presents with bone pain and high blood calcium levels. Imaging reveals lytic bone lesions, and a bone marrow biopsy shows plasma cell proliferation. Which serum protein is likely to be elevated?

Accepted Answer

IgG

Answer

IgA

Answer

C-reactive protein

Answer

Alpha-1 antitrypsin

Question 7

A 35-year-old woman presents with fatigue, weakness, and pallor. Laboratory tests reveal microcytic hypochromic anemia, low serum ferritin, and increased total iron-binding capacity. What is the most likely cause of her condition?

Accepted Answer

Chronic blood loss

Answer

Vitamin B12 deficiency

Answer

Hemolytic anemia

Answer

Thalassemia

Question 8

A patient with fatigue and pallor has a low hemoglobin level and a high total iron-binding capacity (TIBC). Which condition is most likely?

Accepted Answer

Iron Deficiency Anemia

Answer

Anemia of Chronic Disease

Answer

Sideroblastic Anemia

Answer

Hemolytic Anemia

Question 9

Which of these is increased in iron deficiency anemia?

Accepted Answer

Total iron-binding capacity

Answer

Serum ferritin

Answer

Serum transferrin saturation

Answer

Serum iron

Question 10

Which of the following is the MOST COMMON condition that can lead to an abnormal Schilling test?

Accepted Answer

Intrinsic factor deficiency

Answer

None of the options

Answer

Ileal disease

Answer

Chronic pancreatitis

Hematology — MCQs

Hematology — MCQs

On this page

Practice by Chapter

Want unlimited practice?